<p align="center">
  <img src="https://www.hospitaldeamor.com.br/meuapoio/imagens/logo_footer_meu_apoio.png" alt="Hospital de Amor Logo" width="300"/>
</p>

<h1 align="center">ğŸ« Translational Pulmonary Oncology Group (GTOP)</h1>

<p align="center">
  <strong>Strengthening translational research in lung cancer</strong><br>
  From patient care, through molecular pathogenesis, to clinical application using cutting-edge technologies.
</p>

<p align="center">
  <img src="https://img.shields.io/badge/CNPq-Certified-blue" alt="CNPq Certified"/>
  <img src="https://img.shields.io/badge/Hospital%20de%20Amor-Barretos-red" alt="Hospital de Amor"/>
  <img src="https://img.shields.io/badge/Est.-2018-green" alt="Established 2018"/>
</p>

---

## ğŸ“– About Us

The **Translational Lung Oncology Group (GTOP)**, registered and certified by CNPq, was established in mid-2018 at **Hospital de Amor (Barretos Cancer Hospital)**, Brazil. Our mission is to bridge the gap between bench research and bedside care in lung cancer, leveraging state-of-the-art molecular technologies and international collaborations.

---

## ğŸ¯ Objectives

- ğŸ“… Weekly meetings for clinical and molecular knowledge updates
- ğŸ“ Training & mentorship of undergraduate students, residents, and postgraduate scholars
- ğŸ—ƒï¸ Brazil's largest lung cancer database with comprehensive sociodemographic, clinicopathological, and molecular data
- ğŸŒ International consortium participation connecting Hospital de Amor to global research networks
- ğŸ§¬ Comprehensive tumor characterization of NSCLC from genetic and epigenetic perspectives
- ğŸ‡§ğŸ‡· Brazilian-specific insights into lung cancer molecular profiles considering genetic ancestry
- ğŸ§ª Biomarker development for diagnostic, prognostic, and predictive panels at DNA and RNA levels

---

## ğŸ‘¥ Leadership

### Principal Investigator

| Name | Email | CV |
|------|-------|-----|
| **LetÃ­cia Ferro Leal, PhD** | leticiaferro@hotmail.com | [Lattes](http://lattes.cnpq.br/4142456089656080) |

### Co-Founders

| Name | Email | CV |
|------|-------|-----|
| **Pedro De Marchi, MD** | pedrodemarchi@yahoo.com.br | [Lattes](http://lattes.cnpq.br/9351492054565927) |
| **Rui Manuel Vieira Reis, PhD** | ruireis.hcb@gmail.com | [Lattes](http://lattes.cnpq.br/6448722653761487) |

---

## ğŸ”¬ Research Team

<details>
<summary><strong>Collaborating Researchers (17)</strong></summary>

| Name | Email | CV |
|------|-------|-----|
| Alexandre Arthur Jacinto | jacintoaa@gmail.com | [Lattes](http://lattes.cnpq.br/0895348392831490) |
| Ana Carolina Laus | anacarolinalaus@gmail.com | [Lattes](http://lattes.cnpq.br/1351387459879622) |
| Carlos Eduardo Baston Silva | carlos.baston@hotmail.com | [Lattes](http://lattes.cnpq.br/3432698797474201) |
| Eduardo Caetano Albino Da Silva | caetano49@gmail.com | [Lattes](http://lattes.cnpq.br/2983357187517783) |
| Fabiana de Lima Vazquez | fabilivazquez@gmail.com | [Lattes](http://lattes.cnpq.br/2270697027685436) |
| Flavia Escremim de Paula | escremim@gmail.com | [Lattes](http://lattes.cnpq.br/2530079910547080) |
| FlÃ¡vio Augusto Ferreira da Silva | flavio_nx14@hotmail.com | [Lattes](http://lattes.cnpq.br/4357786466071374) |
| Gustavo Dix Junqueira Pinto | gustavodjp@gmail.com | [Lattes](http://lattes.cnpq.br/8185198171243398) |
| Gustavo Noriz Berardinelli | gnoriz@gmail.com | [Lattes](http://lattes.cnpq.br/4117274023679704) |
| Iara Viana Vidigal Santana | iarasantana.hcb@gmail.com | [Lattes](http://lattes.cnpq.br/2547285199031695) |
| Josiane MourÃ£o Dias | josimourao@yahoo.com.br | [Lattes](http://lattes.cnpq.br/5323912744938095) |
| Lidia Maria Rebolho Batista Arantes | lirebolho@hotmail.com | [Lattes](http://lattes.cnpq.br/2019308149950531) |
| Luciane Sussuchi da Silva | lsussuchi@gmail.com | [Lattes](http://lattes.cnpq.br/8102028093010594) |
| Rachid Eduardo Noleto da Nobrega Oliveira | rachidccrr@hotmail.com | [Lattes](http://lattes.cnpq.br/3183281921502962) |
| Renato JosÃ© da Silva Oliveira | renatokjso@gmail.com | [Lattes](http://lattes.cnpq.br/6622719832975698) |
| Rodrigo Sampaio Chiarantano | rodrigo.chiarantano@gmail.com | [Lattes](http://lattes.cnpq.br/9036971600894017) |
| Wanessa Altei | wanaltei@gmail.com | [Lattes](http://lattes.cnpq.br/3727790337302830) |

</details>

<details>
<summary><strong>Current Students & Staff</strong></summary>

| Name | Role | CV |
|------|------|-----|
| Giovanna Maria Stanfoca Casagrande | MSc Student | [Lattes](http://lattes.cnpq.br/2873072836542650) |
| Isabella Lemuqui Tegami | Biologist | [Lattes](http://lattes.cnpq.br/3769643072456473) |
| Maria Fernanda GonÃ§alves | Project Coordinator | [Lattes](http://lattes.cnpq.br/3248394797305974) |

</details>

---

## ğŸŒ International Consortia

<p align="center">
  <img src="https://img.shields.io/badge/IARC-WHO-blue" alt="IARC"/>
  <img src="https://img.shields.io/badge/NIH-NCI-green" alt="NIH NCI"/>
  <img src="https://img.shields.io/badge/ILCCO-Consortium-orange" alt="ILCCO"/>
</p>

- **International Agency for Research on Cancer (IARC/WHO)**
- **NIH National Cancer Institute** â€” Division of Cancer Epidemiology & Genetics
- **International Lung Cancer Consortium (ILCCO)**

---

## ğŸ“š Selected Publications

### 2023

- **Liquid Biopsy for Lung Cancer: Up-to-Date and Perspectives for Screening Programs**  
  Casagrande GMS, Silva MO, Reis RM, Leal LF. *Int J Mol Sci.* 2023;24(3):2505.  
  [![DOI](https://img.shields.io/badge/DOI-10.3390%2Fijms24032505-blue)](https://doi.org/10.3390/ijms24032505)

### 2022

- **EGFR Mutations and PD-L1 Expression in Early-Stage NSCLC: Real-World Data From Brazil**  
  Alves Pinto I, Cavagna RO, et al. *The Oncologist.* 2022.

- **Accounting for EGFR mutations in epidemiological analyses of NSCLC**  
  Schmid S, Jiang M, et al. *Cancer Epidemiol Biomarkers Prev.* 2022;31(3):679-687.

- **Implementation of an Integrated Lung Cancer Prevention and Screening Program Using Mobile CT in Brazil**  
  Chiarantano RS, et al. *Cancer Control.* 2022;29.

### 2021

- **A PCR-Based Approach for Driver Mutation Analysis of EGFR, KRAS, and BRAF in Lung Cancer**  
  de Oliveira Cavagna R, et al. *Methods in Molecular Biology.* Springer US, 2021.

### 2019

- **Mutational profile of Brazilian lung adenocarcinoma: EGFR-Asian ancestry association & KRAS prognostic role**  
  Leal LF, et al. *Sci Rep.* 2019;9(1):3209.  
  [![DOI](https://img.shields.io/badge/DOI-10.1038%2Fs41598--019--39965--x-blue)](https://doi.org/10.1038/s41598-019-39965-x)

---

## ğŸ’° Research Projects

| Project | Funding Agency | Period |
|---------|----------------|--------|
| EGFR mutational status and PD-L1 expression in early-stage NSCLC | AstraZeneca | 2020â€“2021 |
| cfDNA concentration in liquid biopsy samples from NSCLC patients | FAPESP | 2019â€“2020 |
| NGS Mutational Profiling in liquid biopsy from NSCLC patients | IEP Hospital de Amor | 2017â€“2020 |
| miRNA-based biomarkers for lung cancer screening and early detection | FAPESP | 2021â€“2022 |

---

## ğŸ“ Contact

**Hospital de Amor â€” Institute of Teaching and Research**  
ğŸ“ Barretos, SÃ£o Paulo, Brazil  
ğŸ“ +55 (17) 3321-6600  
ğŸŒ [iep.hospitaldeamor.com.br](https://iep.hospitaldeamor.com.br)

---

<p align="center">
  <em>Advancing lung cancer research through translational science and global collaboration.</em>
</p>

<p align="center">
  <img src="https://img.shields.io/badge/Made%20with-â¤ï¸-red" alt="Made with love"/>
  <img src="https://img.shields.io/badge/ğŸ“-Barretos%2C%20Brazil-yellow" alt="Barretos, Brazil"/>
</p>
